Algert Global’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Algert Global’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,515	Closed	-$649K	–	525
2020 Q2	$649K	Buy	+19,515	New	+$621K	0.22%	152
2019 Q3	–	Sell	-11,486	Closed	-$143K	–	467
2019 Q2	$143K	Buy	+11,486	New	+$153K	0.05%	305
2016 Q1	–	Sell	-24,580	Closed	-$365K	–	414
2015 Q4	$365K	Buy	+24,580	New	+$411K	0.17%	218

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Algert Global's MNTA Position: Q3 2020 in Review

Algert Global sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 19,515 shares — an estimated $649K sold.

Algert Global first reported a position in MNTA in Q4 2015 and held it in 3 quarters. The position peaked at $649K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Algert Global reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Algert Global sold 19,515 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $649K.
Algert Global first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
Algert Global's Momenta Pharmaceuticals, Inc. position peaked at $649K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Algert Global's 13F filing for Q3 2020, filed 16 Nov 2020.